The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Recent advances in large-scale production of monoclonal antibodies and related proteins
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Potent antibody therapeutics by design
Carter, P. J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1837 · Cited by 1,099
Post-translational modifications in the context of therapeutic proteins
Walsh, G., & Jefferis, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1252 · Cited by 1,005
Downstream processing of monoclonal antibodies—Application of platform approaches
Shukla, A. A., Hubbard, B., Tressel, T., Guhan, S., & Low, D. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.026 · Cited by 876
Self-citationGlycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829
Bioprocess membrane technology
van Reis, R., & Zydney, A. (2007) · Journal of Membrane Science · doi:10.1016/j.memsci.2007.02.045 · Cited by 773
Optimal and consistent protein glycosylation in mammalian cell culture
Hossler, P., Khattak, S. F., & Li, Z. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp079 · Cited by 669
Industrialization of mAb production technology: The bioprocessing industry at a crossroads
Kelley, B. (2009) · mAbs · doi:10.4161/mabs.1.5.9448 · Cited by 667
Industrial choices for protein production by large-scale cell culture
Chu, L., & Robinson, D. K. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00197-x · Cited by 547
Future of antibody purification
Low, D., O’Leary, R., & Pujar, N. S. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.10.033 · Cited by 472
Birch, J. R., & Racher, A. J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.12.006 · Cited by 471
Development trends for monoclonal antibody cancer therapeutics
Reichert, J. M., & Valge-Archer, V. E. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2241 · Cited by 389
Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations
Kelley, B. (2007) · Biotechnology Progress · doi:10.1021/bp070117s · Cited by 337
A study of monoclonal antibody‐producing CHO cell lines: What makes a stable high producer?
Chusainow, J., Yang, Y. S., Yeo, J. H. M., Toh, P. C., Asvadi, P., Wong, N. S. C., & Yap, M. G. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22158 · Cited by 313
Carbonic anhydrase IX in oligodendroglial brain tumors
Järvelä, S., Parkkila, S., Bragge, H., Kähkönen, M., Parkkila, A.-K., Soini, Y., Pastorekova, S., Pastorek, J., & Haapasalo, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-1 · Cited by 291
Chee Furng Wong, D., Tin Kam Wong, K., Tang Goh, L., Kiat Heng, C., & Gek Sim Yap, M. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20317 · Cited by 231
Basic Concepts in Q Membrane Chromatography for Large-Scale Antibody Production
Zhou, J. X., & Tressel, T. (2006) · Biotechnology Progress · doi:10.1021/bp050425v · Cited by 225
Alternatives to Chromatographic Separations
Thömmes, J., & Etzel, M. R. (2006) · Biotechnology Progress · doi:10.1021/bp0603661 · Cited by 218
Self-citationResponse of a concentrated monoclonal antibody formulation to high shear
Bee, J. S., Stevenson, J. L., Mehta, B., Svitel, J., Pollastrini, J., Platz, R., Freund, E., Carpenter, J. F., & Randolph, T. W. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22336 · Cited by 203
Harris, R. J., Shire, S. J., & Winter, C. (2004) · Drug Development Research · doi:10.1002/ddr.10344 · Cited by 198
Jin, M., Szapiel, N., Zhang, J., Hickey, J., & Ghose, S. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22532 · Cited by 172
Process Scale Purification of Antibodies
(2009) · Wiley eBooks · doi:10.1002/9780470444894 · Cited by 172
Current and future issues in the manufacturing and development of monoclonal antibodies
Kozlowski, S., & Swann, P. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.05.002 · Cited by 170
Fully human therapeutic monoclonal antibodies.
Weiner, L. M. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000192105.24583.83 · Cited by 164
Upstream processes in antibody production: Evaluation of critical parameters
Jain, E., & Kumar, A. (2007) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.09.004 · Cited by 163
Production technologies for monoclonal antibodies and their fragments
Andersen, D. C., & Reilly, D. E. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.08.002 · Cited by 162
Yigzaw, Y., Piper, R., Tran, M., & Shukla, A. A. (2006) · Biotechnology Progress · doi:10.1021/bp050274w · Cited by 161
Self-citationAggregation of a monoclonal antibody induced by adsorption to stainless steel
Bee, J. S., Davis, M., Freund, E., Carpenter, J. F., & Randolph, T. W. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22525 · Cited by 113
Crowell, C. K., Grampp, G. E., Rogers, G. N., Miller, J., & Scheinman, R. I. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21141 · Cited by 111
High‐level protein expression in scalable CHO transient transfection
Ye, J., Kober, V., Tellers, M., Naji, Z., Salmon, P. M., & Markusen, J. F. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22265 · Cited by 108
Jiang, Z., Huang, Y.-L., & Sharfstein, S. T. (2006) · Biotechnology Progress · doi:10.1021/bp0501524 · Cited by 106
McDonald, P., Victa, C., Carter‐Franklin, J. N., & Fahrner, R. L. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22127 · Cited by 99
Affinity-enhanced purification of human antibodies by aqueous two-phase extraction
Azevedo, A. M., Rosa, P. A. J., Ferreira, I. F., Pisco, A. O., de Vries, J., Korporaal, R., Visser, T., & Aires-Barros, M. R. (2008) · Separation and Purification Technology · doi:10.1016/j.seppur.2008.03.006 · Cited by 98
Follow-on biologics: data exclusivity and the balance between innovation and competition
Grabowski, H. G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2532 · Cited by 90
Wagner‐Rousset, E., Bednarczyk, A., Bussat, M., Colas, O., Corvaïa, N., Schaeffer‐Reiss, C., DORSSELAER, A. V., & Beck, A. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.03.032 · Cited by 89
Brorson, K., Brown, J. L., Hamilton, E., & Stein, K. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(02)01697-7 · Cited by 75
Majors, B. S., Betenbaugh, M. J., Pederson, N. E., & Chiang, G. G. (2009) · Biotechnology Progress · doi:10.1002/btpr.192 · Cited by 69
Dineen, S. P., Sullivan, L. A., Beck, A. W., Miller, A. F., Carbon, J. G., Mamluk, R., Wong, H., & Brekken, R. A. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-352 · Cited by 68
Biopharmaceutical drug discovery using novel protein scaffolds
Gill, D. S., & Damle, N. K. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.10.003 · Cited by 67
Novel human antibody therapeutics: The age of the Umabs
Ruuls, S. R., van Bueren, J. J. L., van de Winkel, J. G. J., & Parren, P. W. H. I. (2008) · Biotechnology Journal · doi:10.1002/biot.200800110 · Cited by 67
Lee, C. J., Seth, G., Tsukuda, J., & Hamilton, R. W. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22126 · Cited by 65
Viral clearance using disposable systems in monoclonal antibody commercial downstream processing
Zhou, J. X., Solamo, F., Hong, T., Shearer, M., & Tressel, T. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21781 · Cited by 63
Serum-Free Suspension Large-Scale Transient Transfection of CHO Cells in WAVE Bioreactors
Haldankar, R., Li, D., Saremi, Z., Baikalov, C., & Deshpande, R. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:34:2:191 · Cited by 61
Virus filtration of high‐concentration monoclonal antibody solutions
Marques, B. F., Roush, D. J., & Göklen, K. E. (2009) · Biotechnology Progress · doi:10.1002/btpr.177 · Cited by 47
Estimation of dissolved carbon dioxide stripping in a large bioreactor using model medium
Matsunaga, N., Kano, K., Maki, Y., & Dobashi, T. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2008.11.017 · Cited by 31
Recombinant antibodies for cancer therapy
Deonarain, M. P. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1123 · Cited by 30
Harvest and Recovery of Monoclonal Antibodies from Large-Scale Mammalian Cell Culture
Shukla, A. A., & Kandula, J. R. (2008) · Biopharm international · Cited by 23
Self-citationEngineering properties of a camelid antibody affinity sorbent for Immunoglobulin G purification
Zandian, M., & Jungbauer, A. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.05.051 · Cited by 16
Advances and challenges in developing cytokine fusion proteins as improved therapeutics
Chang, C., Gupta, P. K., & Goldenberg, D. M. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440802702023 · Cited by 14
Development of a rapid sanitization solution for silica-based protein A affinity adsorbents
Rogers, M., Hiraoka-Sutow, M., Mak, P. W. Y., Mann, F., & Lebreton, B. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.03.065 · Cited by 12
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Solid-phase synthesis of molecularly imprinted nanoparticles
Canfarotta, F., Poma, A., Guerreiro, A., & Piletsky, S. (2016) · Nature Protocols · doi:10.1038/nprot.2016.030 · Cited by 407
Trends in Upstream and Downstream Process Development for Antibody Manufacturing
Gronemeyer, P., Ditz, R., & Strube, J. (2014) · Bioengineering · doi:10.3390/bioengineering1040188 · Cited by 329
Single-use disposable technologies for biopharmaceutical manufacturing
Shukla, A. A., & Gottschalk, U. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.10.004 · Cited by 265
Self-citationTechnology trends in antibody purification
Gagnon, P. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2011.10.034 · Cited by 252
Metadata
- Authors
- Shukla, A. A., & Thömmes, J.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 28
- Issue
- 5
- Pages
- 253-261
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W2066833805
- Cited by
- 578
- References
- 52
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.